Skip to main content
SpringerLink
Log in

Parathyromatosis and Parathyroid Cancer

  • Chapter
  • First Online:
Endocrine Neoplasia

Part of the book series: Cancer Treatment and Research ((CTAR,volume 153))

Abstract

Parathyroid carcinoma is a rare entity, accounting for less than 1% of all cases of primary hyperparathyroidism [1–5]. This chapter provides an overview of the clinical presentation, pathophysiology, and medical and surgical management of parathyroid carcinoma and highlights some of the ongoing controversies and areas of current research interest involving this uncommon disease, including: difficulties in distinguishing benign from malignant disease both macroscopically and histologically; recent developments in the understanding of the genetic basis for this disease; the use of calcimimetics and other medical therapies for nonoperative management; and the utility of multiple reoperations in patients with recurrent disease. This chapter also summarizes the current state of knowledge regarding parathyromatosis, defined as an overgrowth of multiple hyperfunctioning nodules of the parathyroid tissue, a condition which may develop after capsular fracture and intraoperative seeding during parathyroid tumor resection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sandelin K (2005) Parathyroid carcinoma. In: Clark OH (ed) Textbook of endocrine surgery, 2nd edn. Elsevier Saunders, Philadelphia, pp 549–554

    Google Scholar 

  2. Lee PK, Jarosek SL, Virnig BA, Evasovich M, Tuttle TM (2007) Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer 109:1736–1741

    Article  PubMed  Google Scholar 

  3. Shane E (2001) Clinical review 122: parathyroid carcinoma. J Clin Endocrinol Metab 86:485–493

    Article  CAS  PubMed  Google Scholar 

  4. Busaidy NL, Jimenez C, Habra MA et al (2004) Parathyroid carcinoma: a 22-year experience. Head Neck 26:716–726

    Article  PubMed  Google Scholar 

  5. Kebebew E (2001) Parathyroid carcinoma. Curr Treat Options Oncol 2:347–354

    Article  CAS  PubMed  Google Scholar 

  6. Iihara M, Okamoto T, Suzuki R et al (2007) Functional parathyroid carcinoma: long-term treatment outcome and risk factor analysis. Surgery 142:936–943; discussion 43 e1

    Google Scholar 

  7. Obara T, Okamoto T, Kanbe M, Iihara M (1997) Functioning parathyroid carcinoma: clinicopathologic features and rational treatment. Semin Surg Oncol 13:134–141

    Article  CAS  PubMed  Google Scholar 

  8. Favia G, Lumachi F, Polistina F, D’Amico DF (1998) Parathyroid carcinoma: sixteen new cases and suggestions for correct management. World J Surg 22:1225–1230

    Article  CAS  PubMed  Google Scholar 

  9. Iacobone M, Lumachi F, Favia G (2004) Up-to-date on parathyroid carcinoma: analysis of an experience of 19 cases. J Surg Oncol 88:223–228

    Article  PubMed  Google Scholar 

  10. Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1999) Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 86:538–544

    Google Scholar 

  11. Kebebew E (2008) Parathyroid carcinoma, a rare but important disorder for endocrinologists, primary care physicians, and endocrine surgeons. Thyroid 18:385–386

    Article  PubMed  Google Scholar 

  12. Fernandez-Ranvier GG, Jensen K, Khanafshar E et al (2007) Nonfunctioning parathyroid carcinoma: case report and review of literature. Endocr Pract 13:750–757

    PubMed  Google Scholar 

  13. Agarwal G, Dhingra S, Mishra SK, Krishnani N (2006) Implantation of parathyroid carcinoma along fine needle aspiration track. Langenbecks Arch Surg 391:623–626

    Article  PubMed  Google Scholar 

  14. Lee JA, Inabnet WB 3rd (2005) The surgeon’s armamentarium to the surgical treatment of primary hyperparathyroidism. J Surg Oncol 89:130–135

    Article  PubMed  Google Scholar 

  15. Arici C, Cheah WK, Ituarte PH et al (2001) Can localization studies be used to direct focused parathyroid operations? Surgery 129:720–729

    Article  CAS  PubMed  Google Scholar 

  16. Yen TW, Wang TS, Doffek KM, Krzywda EA, Wilson SD (2008) Reoperative parathyroidectomy: an algorithm for imaging and monitoring of intraoperative parathyroid hormone levels that results in a successful focused approach. Surgery 144:611–619; discussion 9–21

    Google Scholar 

  17. Kebebew E, Arici C, Duh QY, Clark OH (2001) Localization and reoperation results for persistent and recurrent parathyroid carcinoma. Arch Surg 136:878–885

    Article  CAS  PubMed  Google Scholar 

  18. Placzkowski K, Christian R, Chen H (2007) Radioguided parathyroidectomy for recurrent parathyroid cancer. Clin Nucl Med 32:358–360

    Article  PubMed  Google Scholar 

  19. Clark P, Wooldridge T, Kleinpeter K, Perrier N, Lovato J, Morton K (2004) Providing optimal preoperative localization for recurrent parathyroid carcinoma: a combined parathyroid scintigraphy and computed tomography approach. Clin Nucl Med 29:681–684

    Article  PubMed  Google Scholar 

  20. Clayman GL, Gonzalez HE, El-Naggar A, Vassilopoulou-Sellin R (2004) Parathyroid carcinoma: evaluation and interdisciplinary management. Cancer 100:900–905

    Article  PubMed  Google Scholar 

  21. Wiseman SM, Rigual NR, Hicks WL Jr et al (2004) Parathyroid carcinoma: a multicenter review of clinicopathologic features and treatment outcomes. Ear Nose Throat J 83:491–494

    PubMed  Google Scholar 

  22. Fernandez-Ranvier GG, Khanafshar E, Jensen K et al (2007) Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis? Cancer 110:255–264

    Article  PubMed  Google Scholar 

  23. Lumachi F, Basso SM, Basso U (2006) Parathyroid cancer: etiology, clinical presentation and treatment. Anticancer Res 26:4803–4807

    CAS  PubMed  Google Scholar 

  24. Chang YJ, Mittal V, Remine S et al (2006) Correlation between clinical and histological findings in parathyroid tumors suspicious for carcinoma. Am Surg 72:419–426

    PubMed  Google Scholar 

  25. Sandelin K, Auer G, Bondeson L, Grimelius L, Farnebo LO (1992) Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg 16:724–731

    Article  CAS  PubMed  Google Scholar 

  26. Kameyama K, Takami H (2005) Proposal for the histological classification of parathyroid carcinoma. Endocr Pathol 16:49–52

    Article  PubMed  Google Scholar 

  27. Stojadinovic A, Hoos A, Nissan A et al (2003) Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis. Hum Pathol 34:54–64

    Article  PubMed  Google Scholar 

  28. Cryns VL, Thor A, Xu HJ et al (1994) Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. N Engl J Med 330:757–761

    Article  CAS  PubMed  Google Scholar 

  29. Farnebo F, Auer G, Farnebo LO et al (1999) Evaluation of retinoblastoma and Ki-67 immunostaining as diagnostic markers of benign and malignant parathyroid disease. World J Surg 23:68–74

    Article  CAS  PubMed  Google Scholar 

  30. Tahara H, Smith AP, Gaz RD, Arnold A (1996) Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas. J Clin Endocrinol Metab 81:3663–3667

    Article  CAS  PubMed  Google Scholar 

  31. Shattuck TM, Valimaki S, Obara T et al (2003) Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349:1722–1729

    Article  CAS  PubMed  Google Scholar 

  32. Kirkby-Bott J, Lewis P, Harmer CL, Smellie WJ (2005) One stage treatment of parathyroid cancer. Eur J Surg Oncol 31:78–83

    Article  CAS  PubMed  Google Scholar 

  33. Iacobone M, Ruffolo C, Lumachi F, Favia G (2005) Results of iterative surgery for persistent and recurrent parathyroid carcinoma. Langenbecks Arch Surg 390:385–390

    Article  PubMed  Google Scholar 

  34. Dotzenrath C, Goretzki PE, Sarbia M, Cupisti K, Feldkamp J, Roher HD (2001) Parathyroid carcinoma: problems in diagnosis and the need for radical surgery even in recurrent disease. Eur J Surg Oncol 27:383–389

    Article  CAS  PubMed  Google Scholar 

  35. Sheehan JJ, Hill AD, Walsh MF, Crotty TB, McDermott EW, O’Higgins NJ (2001) Parathyroid carcinoma: diagnosis and management. Eur J Surg Oncol 27:321–324

    Article  CAS  PubMed  Google Scholar 

  36. Bukowski RM, Sheeler L, Cunningham J, Esselstyn C (1984) Successful combination chemotherapy for metastatic parathyroid carcinoma. Arch Intern Med 144:399–400

    Article  CAS  PubMed  Google Scholar 

  37. Bilezikian JP (1992) Management of acute hypercalcemia. N Engl J Med 326:1196–1203

    Article  CAS  PubMed  Google Scholar 

  38. Phitayakorn R, McHenry CR (2008) Hyperparathyroid crisis: use of bisphosphonates as a bridge to parathyroidectomy. J Am Coll Surg 206:1106–1115

    Article  PubMed  Google Scholar 

  39. Block GA, Martin KJ, de Francisco AL et al (2004) Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350:1516–1525

    Article  CAS  PubMed  Google Scholar 

  40. Szmuilowicz ED, Utiger RD (2006) A case of parathyroid carcinoma with hypercalcemia responsive to cinacalcet therapy. Nat Clin Pract Endocrinol Metab 2:291–296; quiz 7

    Google Scholar 

  41. Silverberg SJ, Rubin MR, Faiman C et al (2007) Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. J Clin Endocrinol Metab 92:3803–3808

    Article  CAS  PubMed  Google Scholar 

  42. Calandra DB, Chejfec G, Foy BK, Lawrence AM, Paloyan E (1984) Parathyroid carcinoma: biochemical and pathologic response to DTIC. Surgery 96:1132–1137

    CAS  PubMed  Google Scholar 

  43. Chahinian AP, Holland JF, Nieburgs HE, Marinescu A, Geller SA, Kirschner PA (1981) Metastatic nonfunctioning parathyroid carcinoma: ultrastructural evidence of secretory granules and response to chemotherapy. Am J Med Sci 282:80–84

    Article  CAS  PubMed  Google Scholar 

  44. Munson ND, Foote RL, Northcutt RC et al (2003) Parathyroid carcinoma: is there a role for adjuvant radiation therapy? Cancer 98:2378–2384

    Article  PubMed  Google Scholar 

  45. Kleinpeter KP, Lovato JF, Clark PB et al (2005) Is parathyroid carcinoma indeed a lethal disease? Ann Surg Oncol 12:260–266

    Article  PubMed  Google Scholar 

  46. Fitko R, Roth SI, Hines JR, Roxe DM, Cahill E (1990) Parathyromatosis in hyperparathyroidism. Hum Pathol 21:234–237

    Article  CAS  PubMed  Google Scholar 

  47. Matsuoka S, Tominaga Y, Sato T et al (2007) Recurrent renal hyperparathyroidism caused by parathyromatosis. World J Surg 31:299–305

    Article  PubMed  Google Scholar 

  48. Kollmorgen CF, Aust MR, Ferreiro JA, McCarthy JT, van Heerden JA (1994) Parathyromatosis: a rare yet important cause of persistent or recurrent hyperparathyroidism. Surgery 116:111–115

    CAS  PubMed  Google Scholar 

  49. Tublin ME, Yim JH, Carty SE (2007) Recurrent hyperparathyroidism secondary to parathyromatosis: clinical and imaging findings. J Ultrasound Med 26:847–851

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Section of Endocrine Surgery, Mt. Zion Medical Center, University Of California San Francisco, Hellman Bldg. Room C-349, Campus Box 1674, San Francisco, CA, 94115, USA

    Wen T. Shen

Authors
  1. Wen T. Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wen T. Shen .

Editor information

Editors and Affiliations

  1. Feinberg School of Medicine, Northwestern University, E. Huron St. 201, Chicago, 60611, U.S.A.

    Cord Sturgeon

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Shen, W.T. (2010). Parathyromatosis and Parathyroid Cancer. In: Sturgeon, C. (eds) Endocrine Neoplasia. Cancer Treatment and Research, vol 153. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-0857-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-0857-5_7

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-0856-8

  • Online ISBN: 978-1-4419-0857-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation